Severe Alterations in Lipid Composition of Frontal Cortex Lipid Rafts from Parkinson's Disease and Incidental Parkinson's Disease

被引:287
|
作者
Fabelo, Noemi [2 ]
Martin, Virginia [2 ]
Santpere, Gabriel [3 ]
Marin, Raquel [2 ,4 ]
Torrent, Laia [3 ]
Ferrer, Isidre [3 ]
Diaz, Mario [1 ,2 ]
机构
[1] Univ La Laguna, Dept Anim Biol, Lab Membrane Physiol & Biophys, E-38206 Tenerife, Spain
[2] Univ La Laguna, Inst Tecnol Biomed, E-38206 Tenerife, Spain
[3] Univ Barcelona, Hosp Univ Bellvitge, Inst Neuropatol, Serv Anat Patol, Lhospitalet De Llobregat, Ciberned, Spain
[4] Univ La Laguna, Dept Fisiol, E-38206 Tenerife, Spain
关键词
LEWY BODY DISEASE; POLYUNSATURATED FATTY-ACIDS; HUMAN BRAIN CORTEX; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; MEMBRANE MICRODOMAINS; PHOSPHOLIPASE A(2); SUBSTANTIA-NIGRA;
D O I
10.2119/molmed.2011.00119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid rafts are cholesterol- and sphingomyelin-enriched microdomains that provide a highly saturated and viscous physicochemical microenvironment to promote protein-lipid and protein-protein interactions. We purified lipid rafts from human frontal cortex from normal, early motor stages of Parkinson's disease (PD) and incidental Parkinson's disease (iPD) subjects and analyzed their lipid composition. We observed that lipid rafts from PD and iPD cortices exhibit dramatic reductions in their contents of n-3 and n-6 long-chain polyunsaturated fatty acids, especially docosahexaenoic acid (22:6-n3) and arachidonic acid (20:4n-6). Also, saturated fatty acids (16:0 and 18:0) were significantly higher than in control brains. Paralleling these findings, unsaturation and peroxidability indices were considerably reduced in PD and iPD lipid rafts. Lipid classes were also affected in PD and iPD lipid rafts. Thus, phosphatidylserine and phosphatidylinositol were increased in PD and iPD, whereas cerebrosides and sulfatides and plasmalogen levels were considerably diminished. Our data pinpoint a dramatic increase in lipid raft order due to the aberrant biochemical structure in PD and iPD and indicate that these abnormalities of lipid rafts in the frontal cortex occur at early stages of PD pathology. The findings correlate with abnormal lipid raft signaling and cognitive decline observed during the development of these neurodegenerative disorders. (C) 2011 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: hffp://www.molmed.org doi: 10.2119/molmed.2011.00119
引用
收藏
页码:1107 / 1118
页数:12
相关论文
共 50 条
  • [21] Fatty Acid Composition of the Anterior Cingulate Cortex Indicates a High Susceptibility to Lipid Peroxidation in Parkinson's Disease
    Abbott, Sarah K.
    Jenner, Andrew M.
    Spiro, Adena S.
    Batterham, Marijka
    Halliday, Glenda M.
    Garner, Brett
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (01) : 175 - 185
  • [22] Frontal cortex deficits in Parkinson's disease patients vulnerable to pareidolias
    Revankar, Gajanan
    Hattori, Noriaki
    Kajiyama, Yuta
    Shimokawa, Tetsuya
    Nakano, Tomohito
    Mihara, Masahito
    Mori, Etsuro
    Mochizuki, Hideki
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 299 - 300
  • [23] Frontal dissociations: Evidence from Parkinson's disease
    Gurd, JM
    JOURNAL OF NEUROLINGUISTICS, 1995, 9 (01) : 55 - 68
  • [24] Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease
    Wood, Paul L.
    Tippireddy, Soumya
    Feriante, Joshua
    Woltjer, Randall L.
    PLOS ONE, 2018, 13 (03):
  • [25] Lipid metabolic dysregulation is involved in Parkinson's disease dementia
    Dong, Mei-Xue
    Wei, You-Dong
    Hu, Ling
    METABOLIC BRAIN DISEASE, 2021, 36 (03) : 463 - 470
  • [26] Lipid Nanoparticles: Promising Treatment Approach for Parkinson's Disease
    Jagaran, Keelan
    Singh, Moganavelli
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [27] The role of lipid metabolism in mouse models of Parkinson's disease
    Trabjerg, M.
    Andersen, D.
    Huntjens, P.
    Mork, K.
    Skjonnemand, M.
    Oklinski, M.
    Morkholt, A.
    Huijbers, I.
    Pritchard, C.
    Kroese, L.
    Nieland, J.
    MOVEMENT DISORDERS, 2019, 34 : S734 - S734
  • [28] Lipid pathway dysfunction is prevalent in patients with Parkinson's disease
    Galper, Jasmin
    Dean, Nicholas J.
    Pickford, Russell
    Lewis, Simon J. G.
    Halliday, Glenda M.
    Kim, Woojin S.
    Dzamko, Nicolas
    BRAIN, 2022, 145 (10) : 3472 - 3487
  • [29] Therapeutic potential of lipid nanosystems for the treatment of Parkinson's disease
    Preetam, Subham
    Jonnalagadda, Swathi
    Kumar, Lamha
    Rath, Rajeswari
    Chattopadhyay, Soham
    Alghamdi, Badrah S.
    Abuzenadah, Adel M.
    Jha, Niraj Kumar
    Gautam, Akash
    Malik, Sumira
    Ashraf, Ghulam Md
    AGEING RESEARCH REVIEWS, 2023, 89
  • [30] Pathological role of lipid interaction with α-synuclein in Parkinson's disease
    Suzuki, Mani
    Sango, Kazunori
    Wada, Keiji
    Nagai, Yoshitaka
    NEUROCHEMISTRY INTERNATIONAL, 2018, 119 : 97 - 106